Catalyst Wire Dossier Catalyst Wire Dossier

Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs)

mesenchymal stromal cells · Royan Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs), covering 2016-01-05 to 2016-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD) [Phase 1]

See pricing